Citation

BibTex format

@article{Mall:2025:10.1183/13993003.02435-2024,
author = {Mall, MA and Wainwright, CE and Legg, J and Chilvers, M and Gartner, S and Dittrich, A-M and Stehling, F and Conner, S and Grant, S and Suresh, N and Weinstock, TG and Davies, JC},
doi = {10.1183/13993003.02435-2024},
journal = {EUROPEAN RESPIRATORY JOURNAL},
title = {Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for<i> F508del</i> and a minimal function mutation: results from a 96-week open-label extension study},
url = {http://dx.doi.org/10.1183/13993003.02435-2024},
volume = {66},
year = {2025}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Mall,MA
AU  - Wainwright,CE
AU  - Legg,J
AU  - Chilvers,M
AU  - Gartner,S
AU  - Dittrich,A-M
AU  - Stehling,F
AU  - Conner,S
AU  - Grant,S
AU  - Suresh,N
AU  - Weinstock,TG
AU  - Davies,JC
DO  - 10.1183/13993003.02435-2024
PY  - 2025///
SN  - 0903-1936
TI  - Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for<i> F508del</i> and a minimal function mutation: results from a 96-week open-label extension study
T2  - EUROPEAN RESPIRATORY JOURNAL
UR  - http://dx.doi.org/10.1183/13993003.02435-2024
VL  - 66
ER  -
Download
Read the HIC-Vac blog
  • News
  • Interview

An interview with Professor Openshaw

Professor Peter Openshaw is interviewed by the Infectious Diseases Hub on influenza and immunopathogenesis